Multiplex Assay Kit for Factor Related Apoptosis (FAS) ,etc. by FLIA (Flow Luminescence Immunoassay)

CD95; ALPS1A; ALPS1-A; APO1; APT1; FAS1; FASTM; TNFRSF6; Fas Receptor; TNF Receptor Superfamily Member 6; Tumor Necrosis Factor Receptor Superfamily Member 6

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Factor Related Apoptosis (FAS) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Factor Related Apoptosis (FAS) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Factor Related Apoptosis (FAS) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Factor Related Apoptosis (FAS) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 79-91 82
EDTA plasma(n=5) 80-94 84
heparin plasma(n=5) 87-94 91
sodium citrate plasma(n=5) 98-105 102

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Factor Related Apoptosis (FAS) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Factor Related Apoptosis (FAS) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Factor Related Apoptosis (FAS) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 83-91% 93-101% 88-95% 89-98%
EDTA plasma(n=5) 80-102% 80-94% 79-89% 90-99%
heparin plasma(n=5) 83-94% 78-92% 96-104% 79-103%
sodium citrate plasma(n=5) 86-102% 95-103% 83-97% 81-97%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:FAS) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
European Journal of Pharmacology Montelukast abrogates rhabdomyolysis-induced acute renal failure via rectifying detrimental changes in antioxidant profile and systemic cytokines and apoptotic factors production ScienceDirect: S0014299912002580
J Sci Food Agric. Beneficial effects of Allium sativum L. stem extract on lipid metabolism and antioxidant status in obese mice fed a high fat diet Wiley: Source
Tumor Biology The diplotype Fas? 1377A/? 670G as a genetic marker to predict a lower risk of breast cancer in Chinese women Springer:Source
Naunyn Schmiedebergs Arch Pharmacol The multi-kinase inhibitor pazopanib targets hepatic stellate cell activation and apoptosis alleviating progression of liver fibrosis PubMed: 26269412
Pharmacological Reports The heat shock protein 90 inhibitor, 18-AAG, attenuates thioacetamide induced liver fibrosis in mice Science: Article
PLoS One Aronia melanocarpa Extract Ameliorates Hepatic Lipid Metabolism through PPARγ2 Downregulation 10.1371
Molecular Diagnosis & Therapy The Utility of Biomarkers in Osteoporosis Management pubmed:28271451
PLoS One Aronia melanocarpa Extract Ameliorates Hepatic Lipid Metabolism through PPARγ2 Downregulation pubmed:28081181
Journal of Microbiology, Immunology and Infection Identification of a panel of serum protein markers in early stage of sepsis and its validation in a cohort of patients pubmed:28655573
Journal of Functional Foods Polysaccharides from Cyclocarya paliurus: Chemical composition and lipid-lowering effect on rats challenged with high-fat diet 10.1016/j.jff.2017.07.020
Toxics Zinc Oxide Nanoparticles Induced Oxidative DNA Damage, Inflammation and Apoptosis in Rat's Brain after Oral Exposure Pubmed:29861430
Indian Journal of Medical and Paediatric Oncology The correlation between the level of doxorubicin-induced cardiac damage and serum soluble Fas in an experimental rat model Doi: 10.4103/ijmpo.ijmpo_82_17
Scientific Reports EGF-mediated reduced miR-92a-1-5p controls HTR-8/SVneo cell invasion through activation of MAPK8 and FAS which in turn increase MMP-2/-9 expression Pubmed: 32703964
Catalog No. Related products for research use of Rattus norvegicus (Rat) Organism species Applications (RESEARCH USE ONLY!)
EPA030Ra62 Eukaryotic Factor Related Apoptosis (FAS) Positive Control; Immunogen; SDS-PAGE; WB.
EPA030Ra61 Eukaryotic Factor Related Apoptosis (FAS) Positive Control; Immunogen; SDS-PAGE; WB.
RPA030Ra03 Recombinant Factor Related Apoptosis (FAS) Positive Control; Immunogen; SDS-PAGE; WB.
RPA030Ra01 Recombinant Factor Related Apoptosis (FAS) Positive Control; Immunogen; SDS-PAGE; WB.
RPA030Ra02 Recombinant Factor Related Apoptosis (FAS) Positive Control; Immunogen; SDS-PAGE; WB.
APA030Ra61 Active Factor Related Apoptosis (FAS) Cell culture; Activity Assays.
PAA030Ra02 Polyclonal Antibody to Factor Related Apoptosis (FAS) WB; IHC; ICC; IP.
PAA030Ra06 Polyclonal Antibody to Factor Related Apoptosis (FAS) WB; IHC; ICC; IP.
PAA030Ra03 Polyclonal Antibody to Factor Related Apoptosis (FAS) WB; IHC; ICC; IP.
PAA030Ra01 Polyclonal Antibody to Factor Related Apoptosis (FAS) WB; IHC; ICC; IP.
LAA030Ra81 FITC-Linked Polyclonal Antibody to Factor Related Apoptosis (FAS) WB; IHC; ICC; IF.
LAA030Ra71 Biotin-Linked Polyclonal Antibody to Factor Related Apoptosis (FAS) WB; IHC; ICC.
MAA030Ra21 Monoclonal Antibody to Factor Related Apoptosis (FAS) WB; IHC; ICC; IP.
SEA030Ra ELISA Kit for Factor Related Apoptosis (FAS) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA030Ra Multiplex Assay Kit for Factor Related Apoptosis (FAS) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.